Anti‐melanogenic effect of exosomes derived from human dermal fibroblasts (BJ‐5ta‐Ex) in C57BL/6 mice and B16F10 melanoma cells

Abstract

AbstractExosomes are involved in intercellular communication by transferring cargo between cells and altering the specific functions of the target cells. Recent studies have demonstrated the therapeutic effects of exosomes in several skin diseases. However, understanding of the effects of exosomes on anti‐pigmentation is limited. Therefore, we investigated whether BJ‐5ta exosomes (BJ‐5ta‐Ex) derived from human foreskin fibroblasts regulate melanogenesis and delineated the underlying mechanism. Interestingly, treatment with BJ‐5ta‐Ex induced decreased melanin content, tyrosinase (TYR) activity, and expression of melanogenesis‐related genes, including microphthalmia‐related transcription factor (MITF), TYR, tyrosinase‐related protein‐1 (TRP1), and tyrosinase‐related protein‐2 (TRP2). In addition, BJ‐5ta‐Ex downregulated the cAMP/PKA and GSK‐3β/β‐catenin signaling pathways and upregulated the MAPK/ERK signaling pathway. Notably, treatment with BJ‐5ta‐Ex inhibited α‐melanocyte‐stimulating hormone‐induced melanosome transport and decreased the expression of key proteins involved in melanosome transport, namely, rab27a and melanophilin (MLPH). To further confirm the depigmenting effects of BJ‐5ta‐Ex, we conducted experiments using a three‐dimensional reconstituted human full skin model and ultraviolet B (UVB)‐irradiated mouse model. Treatment with BJ‐5ta‐Ex improved tissue brightness and reduced the distribution of melanosomes. In UVB‐irradiated mouse ears, BJ‐5ta‐Ex reduced the number of active melanocytes and melanin granules. These results demonstrate that BJ‐5ta‐Ex can be useful for the clinical treatment of hyperpigmentation disorders.